1. Cibas ES, Ali SZ, NCI Thyroid FNA. State of the science conference. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132(5):658–65.
2. Pusztaszeri M, Rossi ED, Auger M, Baloch Z, Bishop J, Bongiovanni M, et al. The Bethesda system for reporting thyroid cytopathology: proposed modifications and updates for the second edition from an international panel. Acta Cytol. 2016;60(5):399–405.
3. Ali SZ, Cibas E, editors. The Bethesda system for reporting thyroid cytopathology: definitions, criteria, and explanatory notes [Internet]. 2nd ed. New York: Springer; 2018.
http://www.springer.com/gp/book/9783319605692
. Accessed 18 Jun 2018.
4. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LDR, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023–9.
5. Ali SZ, Cibas E, editors. The Bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes. 2010th ed. New York: Springer; 2010. p. 174.